癌变·畸变·突变 ›› 2007, Vol. 19 ›› Issue (5): 362-365.doi: 10.3969/j.issn.1004-616x.2007.05.005

• 论著 • 上一篇    下一篇

大肠癌Kai_1/CD82基因外显子9区域突变的研究

陈 刚1/ 周建农1/ 尚俊清1/ 张晓梅2/ 陈森清2,   

  1. (1.南京医科大学附属江苏省肿瘤医院普外科结直肠外科组,江苏 南京 210009;2.江苏省肿瘤研究所分子生物室,江苏 南京 210009)
  • 收稿日期:2007-01-04 修回日期:2007-05-09 出版日期:2007-09-30 发布日期:2007-09-30
  • 通讯作者: 陈森清

Mutation of Kai_1/CD82 Gene in Colorectal Cancer

CHEN Gang1,ZHOU Jian_nong1,SHANG Jun_qing1,ZHANG Xiao_mei2,CHEN Sen_qing2,   

  1. (1.Department of General Surgery, Jiangsu Cancer Hospital , Nanjing Medical University, Nanjing 210009;2. Department of Molecular Biology,Jiangsu Cancer Institute,Nanjing 210009,China)
  • Received:2007-01-04 Revised:2007-05-09 Online:2007-09-30 Published:2007-09-30
  • Contact: CHEN Sen_qing

摘要: 背景与目的: 探讨Kai_1/CD82基因外显子9区域的突变在结直肠癌演进与转移中的意义。 材料与方法: 提取40例结直肠癌患者的肿瘤组织(24例无淋巴结转移,16例有淋巴结转移)DNA和RNA,PCR扩增DNA,测序判断Kai_1/CD82基因中外显子9区域的突变情况;RT_PCR后经测序Kai_1/CD82基因外显子9缺失情况。 结果: 40例组织标本中18例出现Kai_1/CD82基因突变;在有淋巴结转移的结直肠癌组织中,突变的频率明显高于无淋巴结转移的结直肠癌组织(P<0.05),在大肠癌中晚期(Dukes C/D期)明显高于早期(Dukes A/B期)(P<0.05),而Kai_1/CD82基因的突变频率与结直肠癌患者的年龄,性别,组织学类型以及分化程度无关(P>0.05)。 结论: Kai_1/CD82基因突变可能与大肠癌演进、转移有关,检测其突变,可以为判断预后、指导临床治疗提供实验依据。

关键词: 大肠癌, Kai_1/CD82基因, 突变, 缺失, 转移

Abstract: BACKGROUND & AIM: To explore the significance of mutation of the exon 9 domain of Kai_1/CD82 gene in the progression and metastasis of colorectal cancer (CRC). MATERIALS AND METHODS: The mutation of the domain of exon 9 was detected by using PCR and judged by sequencing in 40 CRC. The deletion of exon 9 was identified by using RT_PCR and validated by sequencing. RESULTS: The mutation in the Kai_1/CD82 gene was found in 18 of 40 colorectal cases (45%).The frequency of mutation was significantly higher in the colorectal tumors with lymphatic metastasis than those without(P<0.05), and in the advanced stage(Dukes C and D) than in the earlier stage(Dukes A and B) of the cancer (P<0.05). However, there was no significant difference of the mutation frequency when stratified by age and sex of the patients, histological type as well as the degree of differentiation of the CRC (P>0.05). CONCLUSION: The mutation of the Kai_1/CD82 gene was associated with the progression and metastasis of CRC. This can be used for assessing the progression and metatasis of colorectal cancer and for guiding clinical therapy.

Key words: colorectal cancer, Kai_1/CD82 gene, mutation, deletion, metastasis

中图分类号: